

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 8.14846214 |
| 2 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 7.54044860 |
| 3 | ATP synthesis coupled proton transport (GO:0015986) | 7.54044860 |
| 4 | viral transcription (GO:0019083) | 7.00726660 |
| 5 | translational termination (GO:0006415) | 6.65803830 |
| 6 | chaperone-mediated protein transport (GO:0072321) | 6.35898268 |
| 7 | ribosomal small subunit assembly (GO:0000028) | 6.24899409 |
| 8 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 6.20881640 |
| 9 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 6.19452794 |
| 10 | cotranslational protein targeting to membrane (GO:0006613) | 6.12714099 |
| 11 | protein targeting to ER (GO:0045047) | 6.09705063 |
| 12 | respiratory electron transport chain (GO:0022904) | 6.09009724 |
| 13 | electron transport chain (GO:0022900) | 5.96332420 |
| 14 | ribosomal small subunit biogenesis (GO:0042274) | 5.88247976 |
| 15 | L-phenylalanine catabolic process (GO:0006559) | 5.87619210 |
| 16 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.87619210 |
| 17 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 5.82036602 |
| 18 | protein localization to endoplasmic reticulum (GO:0070972) | 5.80963987 |
| 19 | translational elongation (GO:0006414) | 5.80176878 |
| 20 | L-phenylalanine metabolic process (GO:0006558) | 5.62639658 |
| 21 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.62639658 |
| 22 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 5.61045588 |
| 23 | protein complex biogenesis (GO:0070271) | 5.49371439 |
| 24 | viral life cycle (GO:0019058) | 5.23597086 |
| 25 | maturation of SSU-rRNA (GO:0030490) | 5.16727993 |
| 26 | mitochondrial respiratory chain complex assembly (GO:0033108) | 5.10870341 |
| 27 | cellular protein complex disassembly (GO:0043624) | 5.05790702 |
| 28 | drug transmembrane transport (GO:0006855) | 4.96212814 |
| 29 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.92701334 |
| 30 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.88658384 |
| 31 | glyoxylate metabolic process (GO:0046487) | 4.88514192 |
| 32 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.87178782 |
| 33 | NADH dehydrogenase complex assembly (GO:0010257) | 4.87178782 |
| 34 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.87178782 |
| 35 | translational initiation (GO:0006413) | 4.81495109 |
| 36 | cysteine metabolic process (GO:0006534) | 4.81266061 |
| 37 | aromatic amino acid family catabolic process (GO:0009074) | 4.60448905 |
| 38 | protein neddylation (GO:0045116) | 4.57765464 |
| 39 | ribosomal large subunit biogenesis (GO:0042273) | 4.53459123 |
| 40 | translation (GO:0006412) | 4.47216720 |
| 41 | ATP biosynthetic process (GO:0006754) | 4.38860811 |
| 42 | proteasome assembly (GO:0043248) | 4.36495111 |
| 43 | regulation of mitochondrial translation (GO:0070129) | 4.31165676 |
| 44 | protein complex disassembly (GO:0043241) | 4.28218266 |
| 45 | fatty acid elongation (GO:0030497) | 4.26394346 |
| 46 | drug transport (GO:0015893) | 4.20959019 |
| 47 | urate metabolic process (GO:0046415) | 4.20161958 |
| 48 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.18695285 |
| 49 | oxidative phosphorylation (GO:0006119) | 4.15626257 |
| 50 | protein targeting to membrane (GO:0006612) | 4.14433700 |
| 51 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 4.13912678 |
| 52 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 4.12067972 |
| 53 | hydrogen ion transmembrane transport (GO:1902600) | 4.11919034 |
| 54 | macromolecular complex disassembly (GO:0032984) | 4.09337134 |
| 55 | DNA deamination (GO:0045006) | 4.07651695 |
| 56 | serine family amino acid biosynthetic process (GO:0009070) | 4.04217219 |
| 57 | sulfur amino acid catabolic process (GO:0000098) | 4.03343103 |
| 58 | branched-chain amino acid catabolic process (GO:0009083) | 4.02428052 |
| 59 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.97526499 |
| 60 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.92192740 |
| 61 | aldehyde catabolic process (GO:0046185) | 3.87990226 |
| 62 | lysine catabolic process (GO:0006554) | 3.87803037 |
| 63 | lysine metabolic process (GO:0006553) | 3.87803037 |
| 64 | branched-chain amino acid metabolic process (GO:0009081) | 3.87432668 |
| 65 | response to mercury ion (GO:0046689) | 3.86575319 |
| 66 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.86407028 |
| 67 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.86407028 |
| 68 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.85849303 |
| 69 | sequestering of actin monomers (GO:0042989) | 3.85574332 |
| 70 | protein targeting to mitochondrion (GO:0006626) | 3.83931646 |
| 71 | negative regulation of ligase activity (GO:0051352) | 3.83591476 |
| 72 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.83591476 |
| 73 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.82593458 |
| 74 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.78467999 |
| 75 | termination of RNA polymerase III transcription (GO:0006386) | 3.77119420 |
| 76 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.77119420 |
| 77 | cytochrome complex assembly (GO:0017004) | 3.73728900 |
| 78 | cellular component biogenesis (GO:0044085) | 3.73637197 |
| 79 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.73498528 |
| 80 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.73498528 |
| 81 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.73498528 |
| 82 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.73156336 |
| 83 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.73156336 |
| 84 | serine family amino acid metabolic process (GO:0009069) | 3.71403995 |
| 85 | establishment of protein localization to mitochondrion (GO:0072655) | 3.68404276 |
| 86 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.67398672 |
| 87 | valine metabolic process (GO:0006573) | 3.67255614 |
| 88 | proton transport (GO:0015992) | 3.64625105 |
| 89 | tryptophan metabolic process (GO:0006568) | 3.63780769 |
| 90 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 3.63700611 |
| 91 | aromatic amino acid family metabolic process (GO:0009072) | 3.63657969 |
| 92 | glutathione derivative biosynthetic process (GO:1901687) | 3.63399636 |
| 93 | glutathione derivative metabolic process (GO:1901685) | 3.63399636 |
| 94 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.61111986 |
| 95 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.61111986 |
| 96 | very long-chain fatty acid metabolic process (GO:0000038) | 3.60620807 |
| 97 | indole-containing compound catabolic process (GO:0042436) | 3.58151231 |
| 98 | indolalkylamine catabolic process (GO:0046218) | 3.58151231 |
| 99 | tryptophan catabolic process (GO:0006569) | 3.58151231 |
| 100 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.58033770 |
| 101 | ethanol oxidation (GO:0006069) | 3.57486317 |
| 102 | aspartate family amino acid catabolic process (GO:0009068) | 3.57183679 |
| 103 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.57109888 |
| 104 | alpha-linolenic acid metabolic process (GO:0036109) | 3.55841112 |
| 105 | bile acid biosynthetic process (GO:0006699) | 3.55624203 |
| 106 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.55546243 |
| 107 | hydrogen transport (GO:0006818) | 3.55446224 |
| 108 | organic cation transport (GO:0015695) | 3.53615728 |
| 109 | short-chain fatty acid metabolic process (GO:0046459) | 3.52556674 |
| 110 | glutathione biosynthetic process (GO:0006750) | 3.52456618 |
| 111 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.51859441 |
| 112 | protein localization to mitochondrion (GO:0070585) | 3.47868028 |
| 113 | glutathione metabolic process (GO:0006749) | 3.46403635 |
| 114 | signal peptide processing (GO:0006465) | 3.45734977 |
| 115 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.45305710 |
| 116 | inner mitochondrial membrane organization (GO:0007007) | 3.44682196 |
| 117 | fatty acid beta-oxidation (GO:0006635) | 3.41691864 |
| 118 | L-serine metabolic process (GO:0006563) | 3.40997803 |
| 119 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.37984037 |
| 120 | mRNA catabolic process (GO:0006402) | 3.37878870 |
| 121 | base-excision repair, AP site formation (GO:0006285) | 3.37159047 |
| 122 | cellular ketone body metabolic process (GO:0046950) | 3.36350757 |
| 123 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.35183063 |
| 124 | tyrosine metabolic process (GO:0006570) | 3.34618680 |
| 125 | serine family amino acid catabolic process (GO:0009071) | 3.33912361 |
| 126 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.33434778 |
| 127 | respiratory chain complex IV assembly (GO:0008535) | 3.31403188 |
| 128 | rRNA modification (GO:0000154) | 3.31029750 |
| 129 | nucleoside triphosphate biosynthetic process (GO:0009142) | 3.29146853 |
| 130 | GDP-mannose metabolic process (GO:0019673) | 3.28762557 |
| 131 | drug catabolic process (GO:0042737) | 3.28746924 |
| 132 | GTP biosynthetic process (GO:0006183) | 3.27223984 |
| 133 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.27181253 |
| 134 | amino acid salvage (GO:0043102) | 3.26490948 |
| 135 | L-methionine salvage (GO:0071267) | 3.26490948 |
| 136 | L-methionine biosynthetic process (GO:0071265) | 3.26490948 |
| 137 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.25745373 |
| 138 | fatty acid catabolic process (GO:0009062) | 3.25639492 |
| 139 | coenzyme catabolic process (GO:0009109) | 3.24558036 |
| 140 | cellular amino acid catabolic process (GO:0009063) | 3.24124027 |
| 141 | amino-acid betaine metabolic process (GO:0006577) | 3.23683309 |
| 142 | fatty acid oxidation (GO:0019395) | 3.22781176 |
| 143 | alpha-amino acid catabolic process (GO:1901606) | 3.22463772 |
| 144 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.21052852 |
| 145 | mitochondrial transport (GO:0006839) | 3.19094758 |
| 146 | positive regulation of ligase activity (GO:0051351) | 3.19069574 |
| 147 | lipid oxidation (GO:0034440) | 3.18375738 |
| 148 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.17946198 |
| 149 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.17378503 |
| 150 | heme transport (GO:0015886) | 3.16593520 |
| 151 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 3.15222624 |
| 152 | pseudouridine synthesis (GO:0001522) | 3.13262907 |
| 153 | fructose metabolic process (GO:0006000) | 3.12943585 |
| 154 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.10895135 |
| 155 | carboxylic acid catabolic process (GO:0046395) | 3.09360631 |
| 156 | organic acid catabolic process (GO:0016054) | 3.09360631 |
| 157 | RNA catabolic process (GO:0006401) | 3.08997009 |
| 158 | cellular aldehyde metabolic process (GO:0006081) | 3.08479586 |
| 159 | purine nucleoside monophosphate biosynthetic process (GO:0009127) | 3.08111464 |
| 160 | purine ribonucleoside monophosphate biosynthetic process (GO:0009168) | 3.08111464 |
| 161 | tricarboxylic acid metabolic process (GO:0072350) | 3.06890637 |
| 162 | homocysteine metabolic process (GO:0050667) | 3.06266949 |
| 163 | cellular modified amino acid catabolic process (GO:0042219) | 3.03553781 |
| 164 | spliceosomal snRNP assembly (GO:0000387) | 3.02986617 |
| 165 | monocarboxylic acid catabolic process (GO:0072329) | 3.01421246 |
| 166 | establishment of protein localization to membrane (GO:0090150) | 3.01158090 |
| 167 | deoxyribonucleotide catabolic process (GO:0009264) | 3.01148527 |
| 168 | benzene-containing compound metabolic process (GO:0042537) | 2.99651210 |
| 169 | sulfur amino acid metabolic process (GO:0000096) | 2.97672461 |
| 170 | bile acid metabolic process (GO:0008206) | 2.97165174 |
| 171 | kynurenine metabolic process (GO:0070189) | 2.96889996 |
| 172 | thioester metabolic process (GO:0035383) | 2.95922660 |
| 173 | acyl-CoA metabolic process (GO:0006637) | 2.95922660 |
| 174 | regulation of cholesterol metabolic process (GO:0090181) | 2.95346358 |
| 175 | cofactor catabolic process (GO:0051187) | 2.95342514 |
| 176 | acetyl-CoA metabolic process (GO:0006084) | 2.95062074 |
| 177 | ketone body metabolic process (GO:1902224) | 2.93968006 |
| 178 | L-ascorbic acid metabolic process (GO:0019852) | 2.93311537 |
| 179 | response to lead ion (GO:0010288) | 2.91943564 |
| 180 | acyl-CoA biosynthetic process (GO:0071616) | 2.91939366 |
| 181 | thioester biosynthetic process (GO:0035384) | 2.91939366 |
| 182 | NADP metabolic process (GO:0006739) | 2.91852552 |
| 183 | response to misfolded protein (GO:0051788) | 2.91379281 |
| 184 | indolalkylamine metabolic process (GO:0006586) | 2.87735779 |
| 185 | sulfur amino acid biosynthetic process (GO:0000097) | 2.86013998 |
| 186 | response to nitrosative stress (GO:0051409) | 2.85572471 |
| 187 | proline metabolic process (GO:0006560) | 2.84017591 |
| 188 | ethanol metabolic process (GO:0006067) | 2.81857082 |
| 189 | peptide biosynthetic process (GO:0043043) | 2.81679809 |
| 190 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.80661828 |
| 191 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.79984959 |
| 192 | exogenous drug catabolic process (GO:0042738) | 2.78987637 |
| 193 | drug metabolic process (GO:0017144) | 2.78798099 |
| 194 | aspartate family amino acid metabolic process (GO:0009066) | 2.78365959 |
| 195 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.77937628 |
| 196 | glycine metabolic process (GO:0006544) | 2.77747592 |
| 197 | peptide catabolic process (GO:0043171) | 2.75441993 |
| 198 | axon ensheathment in central nervous system (GO:0032291) | 2.75070605 |
| 199 | central nervous system myelination (GO:0022010) | 2.75070605 |
| 200 | phosphate ion transport (GO:0006817) | 2.74912516 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.96964280 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.25380069 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.82454651 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.46302489 |
| 5 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.42661659 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.39035663 |
| 7 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.33083051 |
| 8 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.11353656 |
| 9 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.04168767 |
| 10 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.97934822 |
| 11 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.94040259 |
| 12 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.81960076 |
| 13 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.78812213 |
| 14 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.73036737 |
| 15 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.52484506 |
| 16 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.50186436 |
| 17 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.49400815 |
| 18 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.23892056 |
| 19 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.23029914 |
| 20 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.22193485 |
| 21 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.09532061 |
| 22 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.01663148 |
| 23 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.00177185 |
| 24 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.98608384 |
| 25 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.96985203 |
| 26 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.93469029 |
| 27 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.92465367 |
| 28 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.83357594 |
| 29 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.76570575 |
| 30 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.73839977 |
| 31 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.71038949 |
| 32 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.64852135 |
| 33 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.62893559 |
| 34 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.61286940 |
| 35 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53294126 |
| 36 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.48781375 |
| 37 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.48552549 |
| 38 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.45314295 |
| 39 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.43244119 |
| 40 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.39990992 |
| 41 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.39783993 |
| 42 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.38025899 |
| 43 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.35874244 |
| 44 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.30215820 |
| 45 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.28704921 |
| 46 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.27226918 |
| 47 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.26616009 |
| 48 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.25845608 |
| 49 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.22800814 |
| 50 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.20338801 |
| 51 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.18990771 |
| 52 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.17633130 |
| 53 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.16223325 |
| 54 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.14654797 |
| 55 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.14016036 |
| 56 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.13267233 |
| 57 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.13197868 |
| 58 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.12872753 |
| 59 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.12104681 |
| 60 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.11152213 |
| 61 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.10640028 |
| 62 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09493848 |
| 63 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.08953153 |
| 64 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.07235014 |
| 65 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.06115273 |
| 66 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.04416471 |
| 67 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.04302702 |
| 68 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.03882196 |
| 69 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.03685385 |
| 70 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.03365995 |
| 71 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.03249009 |
| 72 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.03111447 |
| 73 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.02931423 |
| 74 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.02930068 |
| 75 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.02233708 |
| 76 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.01934308 |
| 77 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.01675326 |
| 78 | * TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.01421968 |
| 79 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.01247370 |
| 80 | * YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.01236793 |
| 81 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.01149822 |
| 82 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.00227622 |
| 83 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.99406805 |
| 84 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.99087398 |
| 85 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.99060771 |
| 86 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.98341673 |
| 87 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.97450564 |
| 88 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.97270047 |
| 89 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.96685530 |
| 90 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.95729481 |
| 91 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95297405 |
| 92 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.94836139 |
| 93 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.94240430 |
| 94 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94163170 |
| 95 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.93910454 |
| 96 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.93564955 |
| 97 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.93511689 |
| 98 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.93479295 |
| 99 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.93159903 |
| 100 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.92714318 |
| 101 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.92710326 |
| 102 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.92689450 |
| 103 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.92147996 |
| 104 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.91875956 |
| 105 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.91867035 |
| 106 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.90878841 |
| 107 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.90051407 |
| 108 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.89314388 |
| 109 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.88710779 |
| 110 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.88318802 |
| 111 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.88310463 |
| 112 | AR_20517297_ChIP-Seq_VCAP_Human | 0.87458429 |
| 113 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.87031797 |
| 114 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.86481133 |
| 115 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.86117737 |
| 116 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.85822659 |
| 117 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.85727469 |
| 118 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.85526358 |
| 119 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.85368724 |
| 120 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.84973256 |
| 121 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.84207786 |
| 122 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.84134537 |
| 123 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.83289042 |
| 124 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.82577496 |
| 125 | * ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.82479029 |
| 126 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.82120162 |
| 127 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.81778489 |
| 128 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.81658312 |
| 129 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.81006976 |
| 130 | GATA1_22025678_ChIP-Seq_K562_Human | 0.80762797 |
| 131 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.80626906 |
| 132 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.80523691 |
| 133 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.80282984 |
| 134 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.79989298 |
| 135 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.79838500 |
| 136 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.79566881 |
| 137 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.79286355 |
| 138 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.79205918 |
| 139 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79119959 |
| 140 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.79039783 |
| 141 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.78662626 |
| 142 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.78577823 |
| 143 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.78232687 |
| 144 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.78108000 |
| 145 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.75412693 |
| 146 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.74700494 |
| 147 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.74261004 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009379_abnormal_foot_pigmentation | 5.90734306 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 5.74527837 |
| 3 | MP0005360_urolithiasis | 5.36849529 |
| 4 | MP0003806_abnormal_nucleotide_metabolis | 4.91887955 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.96088363 |
| 6 | MP0003195_calcinosis | 3.89195397 |
| 7 | MP0005365_abnormal_bile_salt | 3.87509222 |
| 8 | MP0005085_abnormal_gallbladder_physiolo | 3.56680261 |
| 9 | MP0005332_abnormal_amino_acid | 3.49143462 |
| 10 | MP0004043_abnormal_pH_regulation | 3.29206011 |
| 11 | MP0009840_abnormal_foam_cell | 3.09712408 |
| 12 | MP0003186_abnormal_redox_activity | 3.03946548 |
| 13 | MP0010030_abnormal_orbit_morphology | 3.01018708 |
| 14 | MP0005058_abnormal_lysosome_morphology | 2.83020101 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.79351553 |
| 16 | MP0006292_abnormal_olfactory_placode | 2.67743935 |
| 17 | MP0009643_abnormal_urine_homeostasis | 2.58237485 |
| 18 | MP0000372_irregular_coat_pigmentation | 2.36453385 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 2.31743568 |
| 20 | MP0005083_abnormal_biliary_tract | 2.26588433 |
| 21 | MP0005636_abnormal_mineral_homeostasis | 2.24656681 |
| 22 | MP0001666_abnormal_nutrient_absorption | 2.22200358 |
| 23 | MP0002277_abnormal_respiratory_mucosa | 2.04520570 |
| 24 | MP0005671_abnormal_response_to | 2.02900598 |
| 25 | MP0003252_abnormal_bile_duct | 2.01872267 |
| 26 | MP0008789_abnormal_olfactory_epithelium | 1.98329949 |
| 27 | MP0010329_abnormal_lipoprotein_level | 1.96603692 |
| 28 | MP0001764_abnormal_homeostasis | 1.89722080 |
| 29 | MP0003191_abnormal_cellular_cholesterol | 1.84148630 |
| 30 | MP0001756_abnormal_urination | 1.81238229 |
| 31 | MP0006036_abnormal_mitochondrial_physio | 1.79028485 |
| 32 | MP0002148_abnormal_hypersensitivity_rea | 1.75678800 |
| 33 | MP0008058_abnormal_DNA_repair | 1.75444576 |
| 34 | MP0004957_abnormal_blastocyst_morpholog | 1.75057831 |
| 35 | MP0004147_increased_porphyrin_level | 1.74462435 |
| 36 | MP0005451_abnormal_body_composition | 1.73544077 |
| 37 | MP0009785_altered_susceptibility_to | 1.72307246 |
| 38 | MP0009333_abnormal_splenocyte_physiolog | 1.70414928 |
| 39 | MP0001765_abnormal_ion_homeostasis | 1.70224208 |
| 40 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.68130279 |
| 41 | MP0003693_abnormal_embryo_hatching | 1.67833802 |
| 42 | MP0002118_abnormal_lipid_homeostasis | 1.67075963 |
| 43 | MP0001661_extended_life_span | 1.66416020 |
| 44 | MP0002938_white_spotting | 1.64517329 |
| 45 | MP0002234_abnormal_pharynx_morphology | 1.63822663 |
| 46 | MP0005319_abnormal_enzyme/_coenzyme | 1.61585381 |
| 47 | MP0003656_abnormal_erythrocyte_physiolo | 1.57247881 |
| 48 | MP0008932_abnormal_embryonic_tissue | 1.53623940 |
| 49 | MP0002837_dystrophic_cardiac_calcinosis | 1.51487944 |
| 50 | MP0006072_abnormal_retinal_apoptosis | 1.48300140 |
| 51 | MP0002653_abnormal_ependyma_morphology | 1.46340714 |
| 52 | MP0005408_hypopigmentation | 1.46323343 |
| 53 | MP0005410_abnormal_fertilization | 1.46268236 |
| 54 | MP0005084_abnormal_gallbladder_morpholo | 1.45454748 |
| 55 | MP0005499_abnormal_olfactory_system | 1.44858924 |
| 56 | MP0005394_taste/olfaction_phenotype | 1.44858924 |
| 57 | MP0001529_abnormal_vocalization | 1.43685423 |
| 58 | MP0000343_altered_response_to | 1.42971888 |
| 59 | MP0002638_abnormal_pupillary_reflex | 1.41858445 |
| 60 | MP0000609_abnormal_liver_physiology | 1.41141473 |
| 61 | MP0003329_amyloid_beta_deposits | 1.41098438 |
| 62 | MP0008260_abnormal_autophagy | 1.40669656 |
| 63 | MP0002136_abnormal_kidney_physiology | 1.39510552 |
| 64 | MP0005377_hearing/vestibular/ear_phenot | 1.36643397 |
| 65 | MP0003878_abnormal_ear_physiology | 1.36643397 |
| 66 | MP0001293_anophthalmia | 1.35920312 |
| 67 | MP0000920_abnormal_myelination | 1.28792916 |
| 68 | MP0003950_abnormal_plasma_membrane | 1.27292128 |
| 69 | MP0002163_abnormal_gland_morphology | 1.26940822 |
| 70 | MP0000049_abnormal_middle_ear | 1.24999085 |
| 71 | MP0004142_abnormal_muscle_tone | 1.21557486 |
| 72 | MP0004782_abnormal_surfactant_physiolog | 1.21444727 |
| 73 | MP0002876_abnormal_thyroid_physiology | 1.20387078 |
| 74 | MP0005075_abnormal_melanosome_morpholog | 1.15977433 |
| 75 | MP0005220_abnormal_exocrine_pancreas | 1.15698131 |
| 76 | MP0003718_maternal_effect | 1.15091830 |
| 77 | MP0003315_abnormal_perineum_morphology | 1.10262504 |
| 78 | MP0000639_abnormal_adrenal_gland | 1.09230707 |
| 79 | MP0003123_paternal_imprinting | 1.09183570 |
| 80 | MP0001958_emphysema | 1.08834412 |
| 81 | MP0005647_abnormal_sex_gland | 1.07379650 |
| 82 | MP0003011_delayed_dark_adaptation | 1.06866024 |
| 83 | MP0000604_amyloidosis | 1.06841248 |
| 84 | MP0002095_abnormal_skin_pigmentation | 1.06820729 |
| 85 | MP0001873_stomach_inflammation | 1.02499007 |
| 86 | MP0003646_muscle_fatigue | 0.98972709 |
| 87 | MP0005025_abnormal_response_to | 0.98027169 |
| 88 | MP0002295_abnormal_pulmonary_circulatio | 0.95342225 |
| 89 | MP0005395_other_phenotype | 0.95150668 |
| 90 | MP0010386_abnormal_urinary_bladder | 0.94394526 |
| 91 | MP0008469_abnormal_protein_level | 0.90254301 |
| 92 | MP0002736_abnormal_nociception_after | 0.89941863 |
| 93 | MP0004133_heterotaxia | 0.89264985 |
| 94 | MP0008007_abnormal_cellular_replicative | 0.88590242 |
| 95 | MP0000598_abnormal_liver_morphology | 0.88115582 |
| 96 | MP0001542_abnormal_bone_strength | 0.87423685 |
| 97 | MP0003077_abnormal_cell_cycle | 0.86251856 |
| 98 | MP0000230_abnormal_systemic_arterial | 0.85206863 |
| 99 | MP0001919_abnormal_reproductive_system | 0.85037468 |
| 100 | MP0001835_abnormal_antigen_presentation | 0.84527475 |
| 101 | MP0009642_abnormal_blood_homeostasis | 0.82575984 |
| 102 | MP0001845_abnormal_inflammatory_respons | 0.82212212 |
| 103 | MP0005376_homeostasis/metabolism_phenot | 0.81025049 |
| 104 | MP0003938_abnormal_ear_development | 0.80201966 |
| 105 | MP0001790_abnormal_immune_system | 0.80004165 |
| 106 | MP0005387_immune_system_phenotype | 0.80004165 |
| 107 | MP0006035_abnormal_mitochondrial_morpho | 0.79879318 |
| 108 | MP0003690_abnormal_glial_cell | 0.79820766 |
| 109 | MP0001485_abnormal_pinna_reflex | 0.79796657 |
| 110 | MP0000750_abnormal_muscle_regeneration | 0.79707219 |
| 111 | MP0002723_abnormal_immune_serum | 0.78072664 |
| 112 | MP0005389_reproductive_system_phenotype | 0.77203835 |
| 113 | MP0004264_abnormal_extraembryonic_tissu | 0.76007824 |
| 114 | MP0002210_abnormal_sex_determination | 0.75520345 |
| 115 | MP0008995_early_reproductive_senescence | 0.74952851 |
| 116 | MP0009765_abnormal_xenobiotic_induced | 0.74255303 |
| 117 | MP0001346_abnormal_lacrimal_gland | 0.73118127 |
| 118 | MP0005000_abnormal_immune_tolerance | 0.72762455 |
| 119 | MP0001905_abnormal_dopamine_level | 0.72684469 |
| 120 | MP0002282_abnormal_trachea_morphology | 0.72497196 |
| 121 | MP0004885_abnormal_endolymph | 0.72490363 |
| 122 | MP0004742_abnormal_vestibular_system | 0.72390885 |
| 123 | MP0002160_abnormal_reproductive_system | 0.72363435 |
| 124 | MP0003638_abnormal_response/metabolism_ | 0.71866427 |
| 125 | MP0004145_abnormal_muscle_electrophysio | 0.70798238 |
| 126 | MP0002168_other_aberrant_phenotype | 0.70040750 |
| 127 | MP0003786_premature_aging | 0.69799299 |
| 128 | MP0005670_abnormal_white_adipose | 0.67835536 |
| 129 | MP0001881_abnormal_mammary_gland | 0.66712710 |
| 130 | MP0002132_abnormal_respiratory_system | 0.66391104 |
| 131 | MP0008872_abnormal_physiological_respon | 0.66314962 |
| 132 | MP0003075_altered_response_to | 0.66198505 |
| 133 | MP0005464_abnormal_platelet_physiology | 0.66066774 |
| 134 | MP0009764_decreased_sensitivity_to | 0.66052843 |
| 135 | MP0001819_abnormal_immune_cell | 0.65643171 |
| 136 | MP0002420_abnormal_adaptive_immunity | 0.65290624 |
| 137 | MP0000538_abnormal_urinary_bladder | 0.64295770 |
| 138 | MP0002078_abnormal_glucose_homeostasis | 0.64094018 |
| 139 | MP0003172_abnormal_lysosome_physiology | 0.63781938 |
| 140 | MP0003868_abnormal_feces_composition | 0.62971905 |
| 141 | MP0005266_abnormal_metabolism | 0.60798712 |
| 142 | MP0009384_cardiac_valve_regurgitation | 0.59075800 |
| 143 | MP0009697_abnormal_copulation | 0.57666916 |
| 144 | MP0006054_spinal_hemorrhage | 0.56279732 |
| 145 | MP0003953_abnormal_hormone_level | 0.55870804 |
| 146 | MP0002135_abnormal_kidney_morphology | 0.55679682 |
| 147 | MP0002254_reproductive_system_inflammat | 0.55437478 |
| 148 | MP0000358_abnormal_cell_content/ | 0.54538096 |
| 149 | MP0005535_abnormal_body_temperature | 0.54067199 |
| 150 | MP0002796_impaired_skin_barrier | 0.52475200 |
| 151 | MP0002229_neurodegeneration | 0.50899303 |
| 152 | MP0001929_abnormal_gametogenesis | 0.50440699 |
| 153 | MP0009763_increased_sensitivity_to | 0.49473903 |
| 154 | MP0006082_CNS_inflammation | 0.49376343 |
| 155 | MP0001853_heart_inflammation | 0.48903953 |
| 156 | MP0003634_abnormal_glial_cell | 0.46583743 |
| 157 | MP0005310_abnormal_salivary_gland | 0.45388337 |
| 158 | MP0001727_abnormal_embryo_implantation | 0.41521711 |
| 159 | MP0005501_abnormal_skin_physiology | 0.41282530 |
| 160 | MP0001944_abnormal_pancreas_morphology | 0.41158456 |
| 161 | MP0000747_muscle_weakness | 0.40652850 |
| 162 | MP0005379_endocrine/exocrine_gland_phen | 0.40449455 |
| 163 | MP0001145_abnormal_male_reproductive | 0.39286405 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased hepatocellular lipid droplets (HP:0006565) | 5.48432450 |
| 2 | Lipid accumulation in hepatocytes (HP:0006561) | 5.11705926 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.99570794 |
| 4 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.52421903 |
| 5 | Gout (HP:0001997) | 4.38040948 |
| 6 | Reticulocytopenia (HP:0001896) | 4.29435503 |
| 7 | Abnormal number of erythroid precursors (HP:0012131) | 4.24525217 |
| 8 | Generalized aminoaciduria (HP:0002909) | 3.98152676 |
| 9 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.97829360 |
| 10 | Exertional dyspnea (HP:0002875) | 3.83258770 |
| 11 | Macrocytic anemia (HP:0001972) | 3.78335349 |
| 12 | Hyperglycinuria (HP:0003108) | 3.64495013 |
| 13 | Abnormality of glycine metabolism (HP:0010895) | 3.63687838 |
| 14 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.63687838 |
| 15 | Intrahepatic cholestasis (HP:0001406) | 3.61418390 |
| 16 | Increased serum lactate (HP:0002151) | 3.55376041 |
| 17 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.53976042 |
| 18 | Proximal tubulopathy (HP:0000114) | 3.43341209 |
| 19 | Exercise intolerance (HP:0003546) | 3.38217824 |
| 20 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.27917847 |
| 21 | Renal salt wasting (HP:0000127) | 3.25897591 |
| 22 | Abnormality of glycolysis (HP:0004366) | 3.21445049 |
| 23 | Increased serum pyruvate (HP:0003542) | 3.21445049 |
| 24 | Glycosuria (HP:0003076) | 3.20999608 |
| 25 | Abnormality of urine glucose concentration (HP:0011016) | 3.20999608 |
| 26 | Hypokalemic alkalosis (HP:0001949) | 3.20927905 |
| 27 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.20368523 |
| 28 | Dicarboxylic aciduria (HP:0003215) | 3.20368523 |
| 29 | Ketosis (HP:0001946) | 3.19314486 |
| 30 | Hyperglycinemia (HP:0002154) | 3.19088724 |
| 31 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 3.14428015 |
| 32 | Respiratory difficulties (HP:0002880) | 3.14314375 |
| 33 | Hypoglycemic coma (HP:0001325) | 3.11055022 |
| 34 | Hepatic necrosis (HP:0002605) | 3.04642446 |
| 35 | Xanthomatosis (HP:0000991) | 3.04085305 |
| 36 | Vacuolated lymphocytes (HP:0001922) | 3.03913537 |
| 37 | Hyperammonemia (HP:0001987) | 3.03636818 |
| 38 | Increased circulating renin level (HP:0000848) | 3.01574905 |
| 39 | Aplastic anemia (HP:0001915) | 2.98227713 |
| 40 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.98082286 |
| 41 | Abnormality of purine metabolism (HP:0004352) | 2.95500547 |
| 42 | Increased purine levels (HP:0004368) | 2.92055796 |
| 43 | Hyperuricemia (HP:0002149) | 2.92055796 |
| 44 | Ketoacidosis (HP:0001993) | 2.88748147 |
| 45 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.88540686 |
| 46 | Lethargy (HP:0001254) | 2.88025914 |
| 47 | Hyperactive renin-angiotensin system (HP:0000841) | 2.85613314 |
| 48 | Acute encephalopathy (HP:0006846) | 2.85503471 |
| 49 | Optic disc pallor (HP:0000543) | 2.85261933 |
| 50 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.82336292 |
| 51 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.76920009 |
| 52 | Hypomagnesemia (HP:0002917) | 2.76692587 |
| 53 | Pallor (HP:0000980) | 2.75077405 |
| 54 | Alkalosis (HP:0001948) | 2.70572038 |
| 55 | Type I transferrin isoform profile (HP:0003642) | 2.64003115 |
| 56 | Cerebral edema (HP:0002181) | 2.62988838 |
| 57 | Methylmalonic aciduria (HP:0012120) | 2.62802745 |
| 58 | Leukodystrophy (HP:0002415) | 2.61601348 |
| 59 | Hyperlipoproteinemia (HP:0010980) | 2.61432473 |
| 60 | Abnormality of renal excretion (HP:0011036) | 2.60599540 |
| 61 | Delayed CNS myelination (HP:0002188) | 2.59850661 |
| 62 | Hepatocellular necrosis (HP:0001404) | 2.58514095 |
| 63 | Polyuria (HP:0000103) | 2.56418961 |
| 64 | Abnormal urine output (HP:0012590) | 2.55265675 |
| 65 | Metabolic acidosis (HP:0001942) | 2.54840828 |
| 66 | Fat malabsorption (HP:0002630) | 2.54387818 |
| 67 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.51392408 |
| 68 | Abnormality of chloride homeostasis (HP:0011422) | 2.50614412 |
| 69 | Abnormality of magnesium homeostasis (HP:0004921) | 2.50553145 |
| 70 | Hypobetalipoproteinemia (HP:0003563) | 2.46466485 |
| 71 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.44879077 |
| 72 | Hyperaldosteronism (HP:0000859) | 2.44535655 |
| 73 | Emotional lability (HP:0000712) | 2.43528978 |
| 74 | Hyperphosphaturia (HP:0003109) | 2.42240667 |
| 75 | Acute necrotizing encephalopathy (HP:0006965) | 2.42083355 |
| 76 | Vomiting (HP:0002013) | 2.41315418 |
| 77 | Abnormality of serum amino acid levels (HP:0003112) | 2.39141051 |
| 78 | Metabolic alkalosis (HP:0200114) | 2.37804722 |
| 79 | Mitochondrial inheritance (HP:0001427) | 2.36017364 |
| 80 | Hypoplasia of the uterus (HP:0000013) | 2.35369889 |
| 81 | Prolonged neonatal jaundice (HP:0006579) | 2.34307579 |
| 82 | Abnormality of nucleobase metabolism (HP:0010932) | 2.33509060 |
| 83 | Abnormality of renin-angiotensin system (HP:0000847) | 2.32532947 |
| 84 | Steatorrhea (HP:0002570) | 2.31972160 |
| 85 | Irritability (HP:0000737) | 2.29963802 |
| 86 | Deep venous thrombosis (HP:0002625) | 2.28713710 |
| 87 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.28303125 |
| 88 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.28303125 |
| 89 | 3-Methylglutaconic aciduria (HP:0003535) | 2.24164075 |
| 90 | Abnormality of renal resorption (HP:0011038) | 2.23773137 |
| 91 | Neurofibrillary tangles (HP:0002185) | 2.21745404 |
| 92 | Malnutrition (HP:0004395) | 2.20491218 |
| 93 | Abnormal protein glycosylation (HP:0012346) | 2.19785495 |
| 94 | Abnormal glycosylation (HP:0012345) | 2.19785495 |
| 95 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.19785495 |
| 96 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.19785495 |
| 97 | Abnormality of methionine metabolism (HP:0010901) | 2.19173389 |
| 98 | Spastic paraparesis (HP:0002313) | 2.19079740 |
| 99 | Oral leukoplakia (HP:0002745) | 2.18684478 |
| 100 | Lactic acidosis (HP:0003128) | 2.16370064 |
| 101 | Opisthotonus (HP:0002179) | 2.15041783 |
| 102 | Polydipsia (HP:0001959) | 2.14938598 |
| 103 | Abnormal drinking behavior (HP:0030082) | 2.14938598 |
| 104 | Pancytopenia (HP:0001876) | 2.14017958 |
| 105 | CNS demyelination (HP:0007305) | 2.13636887 |
| 106 | Renal Fanconi syndrome (HP:0001994) | 2.13385896 |
| 107 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.12844249 |
| 108 | X-linked dominant inheritance (HP:0001423) | 2.12354752 |
| 109 | Increased CSF lactate (HP:0002490) | 2.12157639 |
| 110 | Increased muscle lipid content (HP:0009058) | 2.11440777 |
| 111 | Congenital, generalized hypertrichosis (HP:0004540) | 2.09131297 |
| 112 | Vascular calcification (HP:0004934) | 2.08269367 |
| 113 | Colon cancer (HP:0003003) | 2.07089511 |
| 114 | Brushfield spots (HP:0001088) | 2.06284715 |
| 115 | Prolonged partial thromboplastin time (HP:0003645) | 2.04584970 |
| 116 | Nausea (HP:0002018) | 2.03363668 |
| 117 | Abnormal urine phosphate concentration (HP:0012599) | 2.03299653 |
| 118 | Muscle fiber atrophy (HP:0100295) | 2.02652228 |
| 119 | Rickets (HP:0002748) | 1.98384980 |
| 120 | Respiratory failure (HP:0002878) | 1.98092330 |
| 121 | Abnormality of the intrinsic pathway (HP:0010989) | 1.96845367 |
| 122 | Conjugated hyperbilirubinemia (HP:0002908) | 1.95146432 |
| 123 | Type 2 muscle fiber atrophy (HP:0003554) | 1.95019520 |
| 124 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.94771269 |
| 125 | Progressive macrocephaly (HP:0004481) | 1.92326162 |
| 126 | Microvesicular hepatic steatosis (HP:0001414) | 1.92036857 |
| 127 | Hyperbilirubinemia (HP:0002904) | 1.91726851 |
| 128 | Abnormality of midbrain morphology (HP:0002418) | 1.91450772 |
| 129 | Molar tooth sign on MRI (HP:0002419) | 1.91450772 |
| 130 | Respiratory distress (HP:0002098) | 1.90466232 |
| 131 | Epiphyseal stippling (HP:0010655) | 1.90296166 |
| 132 | Absent thumb (HP:0009777) | 1.90250353 |
| 133 | Increased intramyocellular lipid droplets (HP:0012240) | 1.90214599 |
| 134 | Rough bone trabeculation (HP:0100670) | 1.88781367 |
| 135 | Progressive neurologic deterioration (HP:0002344) | 1.88658572 |
| 136 | Hydroxyprolinuria (HP:0003080) | 1.88392097 |
| 137 | Sclerocornea (HP:0000647) | 1.86892144 |
| 138 | Renal tubular dysfunction (HP:0000124) | 1.86302630 |
| 139 | Microretrognathia (HP:0000308) | 1.85057635 |
| 140 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.84601132 |
| 141 | Methylmalonic acidemia (HP:0002912) | 1.82136725 |
| 142 | Cleft eyelid (HP:0000625) | 1.79544195 |
| 143 | Sparse eyelashes (HP:0000653) | 1.79493022 |
| 144 | Gliosis (HP:0002171) | 1.78265741 |
| 145 | Blindness (HP:0000618) | 1.77258665 |
| 146 | Degeneration of anterior horn cells (HP:0002398) | 1.76178529 |
| 147 | Abnormality of the anterior horn cell (HP:0006802) | 1.76178529 |
| 148 | Pancreatic cysts (HP:0001737) | 1.75132424 |
| 149 | Abnormality of placental membranes (HP:0011409) | 1.74243590 |
| 150 | Amniotic constriction ring (HP:0009775) | 1.74243590 |
| 151 | Stenosis of the external auditory canal (HP:0000402) | 1.71263901 |
| 152 | Pancreatic fibrosis (HP:0100732) | 1.67622775 |
| 153 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.64109883 |
| 154 | Myokymia (HP:0002411) | 1.59946604 |
| 155 | Hypoplastic left heart (HP:0004383) | 1.56639966 |
| 156 | IgM deficiency (HP:0002850) | 1.53451255 |
| 157 | Neutropenia (HP:0001875) | 1.51715155 |
| 158 | Cellular immunodeficiency (HP:0005374) | 1.47934148 |
| 159 | Reduced antithrombin III activity (HP:0001976) | 1.47037509 |
| 160 | Abnormal trabecular bone morphology (HP:0100671) | 1.46168518 |
| 161 | Medial flaring of the eyebrow (HP:0010747) | 1.45241257 |
| 162 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.44261971 |
| 163 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.43660010 |
| 164 | Parakeratosis (HP:0001036) | 1.42558764 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 7.34642740 |
| 2 | BCKDK | 4.68119213 |
| 3 | WNK4 | 4.57781179 |
| 4 | STK39 | 3.93922827 |
| 5 | OXSR1 | 3.91623105 |
| 6 | STK16 | 2.77843149 |
| 7 | WNK3 | 2.58878529 |
| 8 | EPHA2 | 2.45284675 |
| 9 | ZAK | 2.44408066 |
| 10 | MST4 | 2.40238126 |
| 11 | TAF1 | 2.36182838 |
| 12 | NUAK1 | 2.33064053 |
| 13 | TLK1 | 2.19190676 |
| 14 | BUB1 | 2.17350871 |
| 15 | MET | 2.06287606 |
| 16 | PDK3 | 1.93985886 |
| 17 | PDK4 | 1.93985886 |
| 18 | SRPK1 | 1.93035906 |
| 19 | MYLK | 1.93017122 |
| 20 | TESK2 | 1.91496804 |
| 21 | PBK | 1.84592105 |
| 22 | ARAF | 1.84248447 |
| 23 | EPHB1 | 1.78556311 |
| 24 | ERN1 | 1.78052385 |
| 25 | EIF2AK1 | 1.72211569 |
| 26 | TESK1 | 1.57188437 |
| 27 | CDC7 | 1.56195167 |
| 28 | STK38L | 1.52509794 |
| 29 | MAP4K2 | 1.50203758 |
| 30 | CDK8 | 1.48428885 |
| 31 | PDK2 | 1.45309472 |
| 32 | MAPKAPK5 | 1.45250300 |
| 33 | EIF2AK3 | 1.39133761 |
| 34 | BRAF | 1.37889387 |
| 35 | TXK | 1.36635936 |
| 36 | LIMK1 | 1.33110945 |
| 37 | PINK1 | 1.31073793 |
| 38 | NME2 | 1.30122252 |
| 39 | MST1R | 1.29956513 |
| 40 | WEE1 | 1.27467711 |
| 41 | PIM2 | 1.25030690 |
| 42 | FLT3 | 1.17652377 |
| 43 | LRRK2 | 1.13819574 |
| 44 | MAPK15 | 1.12520750 |
| 45 | AKT3 | 1.10150093 |
| 46 | TAOK3 | 1.08033257 |
| 47 | ADRBK2 | 1.07612168 |
| 48 | MAP2K2 | 1.06497731 |
| 49 | BCR | 1.04734505 |
| 50 | PIK3CG | 1.04678190 |
| 51 | SGK494 | 0.99845273 |
| 52 | SGK223 | 0.99845273 |
| 53 | IRAK3 | 0.98974515 |
| 54 | CDK19 | 0.98381243 |
| 55 | DAPK1 | 0.97395073 |
| 56 | FGFR2 | 0.97380059 |
| 57 | CSNK1G3 | 0.94571759 |
| 58 | ABL2 | 0.92938263 |
| 59 | FGFR4 | 0.92263260 |
| 60 | PLK3 | 0.89176621 |
| 61 | DYRK3 | 0.87699636 |
| 62 | PLK4 | 0.87102883 |
| 63 | PRKD3 | 0.85412370 |
| 64 | WNK1 | 0.84872017 |
| 65 | KDR | 0.83429073 |
| 66 | MAP3K12 | 0.80772958 |
| 67 | GRK7 | 0.80191171 |
| 68 | TRIM28 | 0.78472420 |
| 69 | EPHB2 | 0.75841110 |
| 70 | DYRK1B | 0.75785080 |
| 71 | GRK5 | 0.74799774 |
| 72 | IKBKB | 0.74403128 |
| 73 | AURKB | 0.73189698 |
| 74 | BMPR1B | 0.72399494 |
| 75 | PAK4 | 0.71814134 |
| 76 | DYRK2 | 0.70210485 |
| 77 | GRK1 | 0.66634781 |
| 78 | CSNK2A2 | 0.66157553 |
| 79 | BRSK2 | 0.65855592 |
| 80 | SMG1 | 0.65770475 |
| 81 | CSNK2A1 | 0.63230131 |
| 82 | FRK | 0.62454295 |
| 83 | MAP2K7 | 0.62027179 |
| 84 | NEK1 | 0.61536402 |
| 85 | CAMK2G | 0.61524552 |
| 86 | MAP3K2 | 0.60793410 |
| 87 | CSNK1G1 | 0.60437096 |
| 88 | IRAK2 | 0.58856053 |
| 89 | ZAP70 | 0.58746346 |
| 90 | PLK1 | 0.54383494 |
| 91 | ERBB4 | 0.53926212 |
| 92 | CSNK1A1L | 0.52337192 |
| 93 | NME1 | 0.50841236 |
| 94 | TBK1 | 0.49220629 |
| 95 | TYK2 | 0.48184502 |
| 96 | PASK | 0.47550879 |
| 97 | CHEK2 | 0.47366788 |
| 98 | PAK1 | 0.46575229 |
| 99 | PRKCI | 0.46396976 |
| 100 | CDK9 | 0.45754132 |
| 101 | RPS6KB2 | 0.45670870 |
| 102 | INSRR | 0.45387338 |
| 103 | STK10 | 0.44796537 |
| 104 | MAPKAPK3 | 0.43410345 |
| 105 | CDK7 | 0.42994130 |
| 106 | MUSK | 0.42293805 |
| 107 | IRAK1 | 0.42266492 |
| 108 | CSNK1G2 | 0.40986209 |
| 109 | MAP3K3 | 0.38837414 |
| 110 | MAP3K11 | 0.38705908 |
| 111 | AURKA | 0.38686669 |
| 112 | STK4 | 0.38196091 |
| 113 | MAP2K6 | 0.37617029 |
| 114 | DAPK3 | 0.37211991 |
| 115 | RPS6KA5 | 0.37055865 |
| 116 | CAMK2B | 0.35555829 |
| 117 | VRK1 | 0.35328554 |
| 118 | CAMK2D | 0.35003050 |
| 119 | CCNB1 | 0.34862234 |
| 120 | ROCK2 | 0.34176482 |
| 121 | NEK9 | 0.34027768 |
| 122 | MAP4K1 | 0.33011701 |
| 123 | PRKCD | 0.32470553 |
| 124 | TIE1 | 0.32291444 |
| 125 | MAP2K1 | 0.32028454 |
| 126 | IKBKE | 0.31780151 |
| 127 | TTK | 0.31493727 |
| 128 | ADRBK1 | 0.30980101 |
| 129 | PTK2 | 0.30867477 |
| 130 | ILK | 0.30730412 |
| 131 | ATR | 0.30424964 |
| 132 | MAP3K8 | 0.30122999 |
| 133 | PRKCQ | 0.29658444 |
| 134 | SIK1 | 0.29274322 |
| 135 | BRSK1 | 0.28760086 |
| 136 | CSNK1A1 | 0.28141214 |
| 137 | NEK6 | 0.28004318 |
| 138 | SCYL2 | 0.27232229 |
| 139 | NTRK1 | 0.27039274 |
| 140 | GSK3A | 0.25685237 |
| 141 | TGFBR1 | 0.25531451 |
| 142 | MOS | 0.25504358 |
| 143 | TAOK2 | 0.25108091 |
| 144 | CDK11A | 0.24984627 |
| 145 | CDK14 | 0.23947624 |
| 146 | KSR2 | 0.23503142 |
| 147 | EIF2AK2 | 0.20627314 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.68030808 |
| 2 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.55438107 |
| 3 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.50770491 |
| 4 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.47772518 |
| 5 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.45251276 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.43428028 |
| 7 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.37780815 |
| 8 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.25221403 |
| 9 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.21704422 |
| 10 | Peroxisome_Homo sapiens_hsa04146 | 2.18802433 |
| 11 | Protein export_Homo sapiens_hsa03060 | 2.18120861 |
| 12 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.17527644 |
| 13 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.16895548 |
| 14 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.14423386 |
| 15 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.13660869 |
| 16 | DNA replication_Homo sapiens_hsa03030 | 2.09813085 |
| 17 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.08560228 |
| 18 | Mismatch repair_Homo sapiens_hsa03430 | 2.04688674 |
| 19 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.04346260 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.98980294 |
| 21 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.98765293 |
| 22 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.96378002 |
| 23 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.94801180 |
| 24 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.88948575 |
| 25 | Homologous recombination_Homo sapiens_hsa03440 | 1.82927800 |
| 26 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.82180395 |
| 27 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.81070698 |
| 28 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.72215133 |
| 29 | Proteasome_Homo sapiens_hsa03050 | 1.71150777 |
| 30 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.70255530 |
| 31 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.66524691 |
| 32 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.65179077 |
| 33 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.60554414 |
| 34 | Base excision repair_Homo sapiens_hsa03410 | 1.58823815 |
| 35 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.55561952 |
| 36 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.53813607 |
| 37 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.51651552 |
| 38 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.51350647 |
| 39 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.49360644 |
| 40 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.47144120 |
| 41 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.46414974 |
| 42 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.46266060 |
| 43 | Carbon metabolism_Homo sapiens_hsa01200 | 1.43112296 |
| 44 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.42080819 |
| 45 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.41506001 |
| 46 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.40913944 |
| 47 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.35698667 |
| 48 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.34562070 |
| 49 | Spliceosome_Homo sapiens_hsa03040 | 1.27836509 |
| 50 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.24947254 |
| 51 | Parkinsons disease_Homo sapiens_hsa05012 | 1.24795220 |
| 52 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.21947063 |
| 53 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.20286470 |
| 54 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.19242028 |
| 55 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.16431924 |
| 56 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.16208964 |
| 57 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.15039986 |
| 58 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.14948239 |
| 59 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.13530505 |
| 60 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.11705772 |
| 61 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.10521588 |
| 62 | Retinol metabolism_Homo sapiens_hsa00830 | 1.08918752 |
| 63 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.08754586 |
| 64 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.06026604 |
| 65 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.05622236 |
| 66 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.01431701 |
| 67 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.01086082 |
| 68 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.00461152 |
| 69 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.96406472 |
| 70 | Other glycan degradation_Homo sapiens_hsa00511 | 0.95246194 |
| 71 | Metabolic pathways_Homo sapiens_hsa01100 | 0.93744752 |
| 72 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.92661712 |
| 73 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.92651452 |
| 74 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.92591649 |
| 75 | Lysosome_Homo sapiens_hsa04142 | 0.92261387 |
| 76 | Sulfur relay system_Homo sapiens_hsa04122 | 0.91009802 |
| 77 | RNA degradation_Homo sapiens_hsa03018 | 0.89651934 |
| 78 | Asthma_Homo sapiens_hsa05310 | 0.88515178 |
| 79 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.88040471 |
| 80 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.87630033 |
| 81 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.87349618 |
| 82 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.85389203 |
| 83 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.85361154 |
| 84 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.82237209 |
| 85 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.81361500 |
| 86 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.80279612 |
| 87 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.79626638 |
| 88 | RNA polymerase_Homo sapiens_hsa03020 | 0.79436089 |
| 89 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.79285399 |
| 90 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.77043008 |
| 91 | Allograft rejection_Homo sapiens_hsa05330 | 0.76493392 |
| 92 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.75787867 |
| 93 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.75715472 |
| 94 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.73718140 |
| 95 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.72072907 |
| 96 | Bile secretion_Homo sapiens_hsa04976 | 0.70421260 |
| 97 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.70381589 |
| 98 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.69999675 |
| 99 | Alzheimers disease_Homo sapiens_hsa05010 | 0.69671071 |
| 100 | Huntingtons disease_Homo sapiens_hsa05016 | 0.69537487 |
| 101 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.68671921 |
| 102 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.68090695 |
| 103 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.67976311 |
| 104 | RNA transport_Homo sapiens_hsa03013 | 0.66879056 |
| 105 | Mineral absorption_Homo sapiens_hsa04978 | 0.62110528 |
| 106 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.58906369 |
| 107 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.58248056 |
| 108 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.55307253 |
| 109 | Ribosome_Homo sapiens_hsa03010 | 0.48144813 |
| 110 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.47674645 |
| 111 | ABC transporters_Homo sapiens_hsa02010 | 0.46268282 |
| 112 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.44917839 |
| 113 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.44068708 |
| 114 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.37477712 |
| 115 | Galactose metabolism_Homo sapiens_hsa00052 | 0.35931296 |
| 116 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.34097197 |
| 117 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.29168534 |
| 118 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.28281868 |
| 119 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.27597579 |
| 120 | Purine metabolism_Homo sapiens_hsa00230 | 0.25143392 |
| 121 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.25138045 |
| 122 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.24003816 |
| 123 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.23225367 |
| 124 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.22989450 |
| 125 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.22573762 |
| 126 | Basal transcription factors_Homo sapiens_hsa03022 | 0.17185311 |
| 127 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.14512684 |
| 128 | Phagosome_Homo sapiens_hsa04145 | 0.13535629 |
| 129 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.10273927 |

